Elevated levels of soluble TNF-α and its receptor (TNF-R1) are detected in the sera of patients with CLL and are associated with a poor clinical outcome [91,97,133,134,135,136] (Table 1). This evidence concerns the gene TNFRSF1A and B-cell chronic lymphocytic leukemia.